No. of Partners: 1
Coordinating Company: Enzymlogic.S.L.
Funding Institution: European Union
The KINETICfinder® project received funding from the SME Instrument within the European Union’s Horizon 2020 research and innovation programme (grant agreement No 867659).
The SME Instrument, as part of the Enhanced European Innovation Council (EIC) pilot, supports high-risk, high-potential small and medium-sized enterprises to develop and bring to market new products, services and business models that could drive economic growth and shape new markets or disrupt existing ones in Europe and worldwide.
The goal of this project is the validation of KINETICfinder®, a robust, accurate and reproducible platform that enables kinetic analysis at scale in the early research stages, when the failure rate is high and thousands of potential drugs are under scrutiny. KINETICfinder® allows pharma companies to preselect the drugs with the greatest possibilities to reach the market.